Adimab LLC United States of America (USA)
Research
Date range: 1 December 2020 - 30 November 2021
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Adimab LLC published between 1 December 2020 - 30 November 2021 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
3 | 0.54 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 3 | 0.54 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.20 | 1.09 | 0.25 | 0.69 | 0.73 |
Collaboration
Date range: 1 December 2020 - 30 November 2021
International vs. domestic collaboration by Share
- 72.54% Domestic
- 27.46% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Adimab LLC by Share (15 total)
-
Adimab LLC and The University of Texas at Austin (UT Austin)
(0.83)
-
Adimab LLC and Albert Einstein College of Medicine (Einstein)
(0.68)
-
Adimab LLC and U.S. Department of Defense (DoD)
(0.60)
-
Adimab LLC and Scripps Research
(0.52)
-
Adimab LLC and Mapp Biopharmaceutical, Inc.
(0.51)
-
Adimab LLC and The University of North Carolina at Chapel Hill (UNC)
(0.50)
-
Adimab LLC and Geneva Foundation
(0.46)
-
Adimab LLC and Adagio Therapeutics, Inc.
(0.44)
-
Adimab LLC and Washington State University (WSU)
(0.39)
-
Adimab LLC and IAVI's Neutralizing Antibody Center at Scripps Research (IAVI-NAC)
(0.32)
Top 10 international collaborators with Adimab LLC by Share (10 total)
-
Adimab LLC and Laboratory of Structural Virology
(0.41)
-
Adimab LLC and French National Centre for Scientific Research (CNRS)
(0.37)
-
Adimab LLC and Pasteur Institute
(0.33)
-
Adimab LLC and International Center for Infectiology Research (CIRI)
(0.29)
-
Adimab LLC and University of Paris
(0.29)
-
Adimab LLC and University of Lyon
(0.21)
-
Adimab LLC and Crystallography Platform
(0.18)
-
Adimab LLC and National Institute for Health and Medical Research (INSERM)
(0.18)
-
Adimab LLC and Uganda Virus Research Institute (UVRI)
(0.16)
-
Adimab LLC and Ben-Gurion University of the Negev (BGU)
(0.12)

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.